Quick filters:
Open Data
Open Code
Pre-registered
Funding Declared
COI Declared
Open Access
Clear Filters
Rivoceranib, a VEGFR-2 inhibitor, monotherapy in previously treated patients with advanced or metastatic gastric or gas…
Kang YK; Ryu MH; Di Bartolomeo M; Chau I; Yoon H; Kim JG; Lee KW; Oh SC; Takashima A; Kryzhanivska A; Chao Y; Evesque L; Schenker M; McGinn A; Zhao Y; Lee J; Wyrwicz L; Boku N.
Gastric Cancer
(Unknown)
Published: 2024
Effect of preoperative chemotherapy on the histopathological classification of gastric cancer.
Caspers IA; Biesma HD; Wiklund K; Pontén F; Lind P; Nordsmark M; Sikorska K; Meershoek-KleinKranenbarg E; Hartgrink HH; van de Velde CJH; van Sandick JW; Verheij M; Cats A; van Grieken NCT.
Gastric Cancer
(Unknown)
Published: 2023
Perioperative TAS-118 plus oxaliplatin in patients with locally advanced gastric cancer: APOLLO-11 study.
Takahari D; Katai H; Takashima A; Izawa N; Ishizuka N; Ohashi M; Mikami S; Wakatsuki T; Nakayama I; Chin K; Ida S; Kumagai K; Nunobe S; Iwasa S; Shoji H; Wada T; Doi A; Yoshikawa T; Sano T; Boku N; Yamaguchi K.
Gastric Cancer
(Unknown)
Published: 2023
The putative pleiotropic functions of meprin β in gastric cancer.
Gastric Cancer
(Unknown)
Published: 2023
Artificial intelligence-guided discovery of gastric cancer continuum.
Gastric Cancer
(Unknown)
Published: 2023
Japanese Gastric Cancer Treatment Guidelines 2021 (6th edition).
Gastric Cancer
(Unknown)
Published: 2022